Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
Abstract Aims To explore the associations between serum phenylacetylglutamine (PAGln) and chronic heart failure (HF). Methods and results Totally 956 subjects were enrolled consecutively from the Department of Cardiovascular Medicine, Ruijin Hospital. Baseline data were obtained from all participant...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.13989 |